CORTELLARO, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 5.286
NA - Nord America 4.147
AS - Asia 3.712
SA - Sud America 388
AF - Africa 108
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.651
Nazione #
US - Stati Uniti d'America 4.015
GB - Regno Unito 1.800
CN - Cina 1.239
SG - Singapore 1.138
IT - Italia 851
SE - Svezia 627
DE - Germania 508
RU - Federazione Russa 414
HK - Hong Kong 269
BR - Brasile 265
UA - Ucraina 262
VN - Vietnam 245
FR - Francia 235
IN - India 234
NL - Olanda 168
KR - Corea 141
TR - Turchia 134
IE - Irlanda 127
EU - Europa 117
FI - Finlandia 102
CA - Canada 101
BD - Bangladesh 87
CO - Colombia 59
PL - Polonia 53
JP - Giappone 44
CI - Costa d'Avorio 43
ID - Indonesia 38
BE - Belgio 23
AR - Argentina 21
IQ - Iraq 20
ZA - Sudafrica 20
ES - Italia 18
PK - Pakistan 18
MX - Messico 17
DK - Danimarca 16
EC - Ecuador 15
GR - Grecia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
MY - Malesia 12
AT - Austria 11
IL - Israele 11
VE - Venezuela 11
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 7
CL - Cile 7
ET - Etiopia 7
MA - Marocco 7
RO - Romania 7
AU - Australia 6
KG - Kirghizistan 6
LU - Lussemburgo 6
SI - Slovenia 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
KZ - Kazakistan 5
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
PE - Perù 4
UY - Uruguay 4
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
TN - Tunisia 3
ZM - Zambia 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
MW - Malawi 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
Totale 13.753
Città #
Southend 1.631
Singapore 590
Ashburn 397
Chandler 378
Beijing 309
San Jose 289
Hong Kong 244
Seattle 218
Jacksonville 215
Milan 192
Princeton 159
Wilmington 139
Dublin 124
Santa Clara 114
Mountain View 112
Council Bluffs 103
Ann Arbor 98
Nanjing 96
Redmond 95
Bengaluru 93
Los Angeles 93
Woodbridge 89
Fairfield 85
Frankfurt am Main 82
Dallas 78
New York 75
Dearborn 74
Ho Chi Minh City 74
Lauterbourg 66
Sakarya 66
Andover 58
Toronto 58
Des Moines 57
Serra 57
Margão 56
Bogotá 52
Boardman 51
Hanoi 49
Guangzhou 48
Somerville 48
Munich 46
Houston 44
Abidjan 43
Buffalo 43
Shanghai 43
Warsaw 43
Moscow 42
Nanchang 42
Hefei 38
Cambridge 37
Tokyo 37
Turin 34
Shenyang 32
Hangzhou 30
Jinan 30
Helsinki 28
Rome 28
Grafing 27
Columbus 26
Brussels 22
Tianjin 22
Phoenix 21
Berlin 20
Jakarta 20
Hanover 18
Ottawa 18
Medford 17
Dong Ket 16
Auburn Hills 15
Cangzhou 15
Changsha 15
Athens 14
Da Nang 14
Hebei 14
Johannesburg 14
Shenzhen 14
São Paulo 14
The Dalles 14
Verona 14
Bitonto 13
Chicago 13
Jiaxing 13
Redwood City 13
Wuhan 13
Eitensheim 12
Kunming 12
Kwai Chung 12
Atlanta 11
Roubaix 11
Roxbury 11
Fuzhou 10
Haiphong 10
Quanzhou 10
Taizhou 10
Zhengzhou 10
Belo Horizonte 9
Brooklyn 9
Chennai 9
London 9
Rio de Janeiro 9
Totale 8.165
Nome #
Un caso di dolore osteo-muscolare non responsivo ai FANS 402
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 347
Calo ponderale e leucocitosi: quale la causa? 329
Are pleiotropic effects of statins real? 293
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 275
Esordio tipico di emorragia cerebrale atipica 268
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 263
Anemia emolitica: malattia o epifenomeno? 244
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 240
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 240
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease 238
Danno d’organo subclinico in una popolazione sovrappeso/obesa a rischio cardiovascolare intermedio 237
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 236
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 234
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 234
Progetto innovativo per migliorare la qualità della prevenzione cardio-cerebrovascolare attraverso un modello di integrazione Ospedale-Territorio e la valutazione di parametri non compresi nella definizione del rischio intermedio – Progetto CAPRESS 233
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 233
Psicosi acuta ed epilessia: quale alterazione metabolica 229
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 229
Relationship between haemostatic variables and the progression of carotid atherosclerosis 229
Hemostatic variables and progression of common carotid intima-media thickness in patients with peripheral arterial disease 221
Un caso da manuale 218
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 216
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 214
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 212
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment 207
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 206
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors : CArdiovascular PREvention Sacco Study (CAPRESS) 206
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 206
Subclinical disease (SD) in overweight and obese individuals at intermediate cardiovascular (CV) risk 202
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 202
Target organ damage in an asymptomatic population at intermediate cardiovascular risk and adjunctive major risk factors : the cardiovascular prevention Sacco study (CAPRESS) 201
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 195
A case of multiorgan atherosclerotic disease in patient affected by hyperhomocistinemia with multiple heterozigous muattions 185
Cirrosi biliare primitiva ama negativa esordita con grave osteoporosi 184
Arteriosclerosi e suscettibilità d'organo 182
Come migliorare la stratificazione del rischio intermedio 181
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 180
Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina : results from the Lescol Intervention Prevention Study (LIPS) 177
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 177
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 177
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 176
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy) 175
Relazione tra variabili emostatiche e modificazioni dell'ispessimento intimale della carotide in pazienti con malattia ischemica periferica 166
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 165
Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement 164
Progetti regionali innovativi area cardiocerebrovascolare 162
Inibitori della COX-2: una promessa non mantenuta? Il parere dell'internista 162
Relation between hemostatic variables and changes of carotid intima-media thickness in PAD patients 162
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 159
null 159
Polineuropatia sensitivo-motoria acuta e febbre : un caso di panarterite 158
Valutazione della lesione d'organo subclinica nei soggetti a rischio cardiovascolare intermedio: un progetto di intehgrazione ospedale-territorio 155
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease : the DAVID study 155
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study 155
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 150
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia 145
Idarubicin in the therapy of acute myeloid leukemia : final analysis in 57 previously untreated patients 144
Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk? 140
Dai grandi trials alla pratica clinica: l’esempio delle statine 137
The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) 137
Dermatan sulphate in acute leukaemia 137
Markers infiammatori solubili ed evoluzione della placca aterosclerotica : effetto del trattamento con statina a dosi moderate in pazienti con cardiopatia ischemica stabile : studio MIAMI 136
The antiatherothrombotic effects of Atorvastatin : the ATROCAP Study results 135
Un insolito caso di malassorbimento 133
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 133
Esiste realmente l'effetto antinfiammatorio delle statine? 130
Flogosi granulomatosa polmonare in B-LLC trattata con fludarabina 128
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 128
Switching statins : an appropriate guideline for clinical practice? 127
Placca o individuo a rischio? 126
Antiatherosclerotic and antiatherothrombotic effects of statins 126
Biomarkers ed evoluzione della placca 118
Progetto pilota di collaborazione tra medici di medicina generale e ospedale per migliorare la valutazione del rischio cardiovascolare in soggetti a rischio intermedio. 114
Inflammatory markers and C-IMT in patients with previous myocardial infarction. The atorvastatin effect. MIAMI Study 97
FVIII-C-VWF-AG, fibrinogen, PAI-1 and leukocytes are associated with ischemic events in vascular-disease patients : the plat study 92
null 4
Totale 14.372
Categoria #
all - tutte 34.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 0 350 70
2021/2022804 90 28 27 41 33 58 83 49 90 51 72 182
2022/20231.238 150 152 112 144 154 226 26 71 139 4 47 13
2023/2024631 20 53 45 35 142 70 11 64 14 19 80 78
2024/20251.865 76 147 19 186 165 90 71 154 117 154 106 580
2025/20263.404 389 201 284 331 314 265 462 158 418 345 237 0
Totale 14.372